Rethinking APOB Levels
The discussion challenges the conventional wisdom surrounding APOB levels and their role in overall mortality. While lowering APOB may reduce cardiovascular risk, its impact on all-cause mortality remains questionable. Emphasizing insulin sensitivity and liver fat, the conversation highlights the complexities of health and the potential downsides of pharmaceutical interventions like PCSK9 inhibitors.In this clip
From this podcast
The Human Upgrade
The Calorie Myth: Why 85% Of Diets Fail! Eat THIS To Lose Weight & Stay Young! Paul Saladino
Related Questions
Should I use statins or PCSK9 inhibitors to lower LDL and apoB as discussed in the episode 242. Debunking Cholesterol Myths: New Study Reveals Surprising Findings! With Dave Feldman and the clip Lipid Lowering Therapy from the episode The Calorie Myth: Why 85% Of Diets Fail! Eat THIS To Lose Weight & Stay Young! Paul Saladino and the clip Rethinking APOB Levels?
Should I use statins or PCSK9 inhibitors to lower LDL and apoB as discussed in the episode 242. Debunking Cholesterol Myths: New Study Reveals Surprising Findings! With Dave Feldman and the clip Lipid Lowering Therapy from the episode The Calorie Myth: Why 85% Of Diets Fail! Eat THIS To Lose Weight & Stay Young! Paul Saladino and the clip Rethinking APOB Levels?
Should I use statins or PCSK9 inhibitors to lower LDL and apoB based on the episode The Calorie Myth: Why 85% Of Diets Fail! Eat THIS To Lose Weight & Stay Young! Paul Saladino and the clip Rethinking APOB Levels from episode 242. Debunking Cholesterol Myths: New Study Reveals Surprising Findings! With Dave Feldman and the clip Challenging Medical Norms?